Tara Gregory
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 23
- CAR-T cell therapy research 18
- Hematology 14
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Jesús G. Berdeja (18 shared papers)Steven Trifilio (2 shared papers)Scott C. Howard (2 shared papers)Ali McBride (2 shared papers)David N. Wald (1 shared paper)William Tse (1 shared paper)Yin Xiong (1 shared paper)Adam D. Cohen (4 shared papers)
- Journals
- Blood (11 papers)Transplantation and Cellular Therapy (5 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Tara Gregory
28 papers receiving 550 citations
Peers
Comparison fields: 5 of 46
- Hematology 268
- Oncology 335
- Molecular Biology 289
- Genetics 40
- Immunology 78
Countries citing papers authored by Tara Gregory
This map shows the geographic impact of Tara Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Gregory more than expected).
Fields of papers citing papers by Tara Gregory
This network shows the impact of papers produced by Tara Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Gregory. The network helps show where Tara Gregory may publish in the future.
Co-authors
The 25 scholars most cited alongside Tara Gregory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 109 | |
| 2 | 2016 | 86 | |
| 3 | 2018 | 70 | |
| 4 | 2020 | 60 | |
| 5 | 2019 | 43 | |
| 6 | 2022 | 32 | |
| 7 | 2023 | 32 | |
| 8 | 2017 | 20 | |
| 9 | 2021 | 13 | |
| 10 | 2023 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2017 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2019 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2015 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2018 | 3 | |
| 20 | 2024 | 2 |
About Tara Gregory
Tara Gregory is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Genetics, having authored 31 papers that have together received 557 indexed citations. Recurring topics across this work include CAR-T cell therapy research (18 papers), Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (7 papers), Biosimilars and Bioanalytical Methods (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (268 citations), Oncology (335 citations), Molecular Biology (289 citations), Genetics (40 citations) and Immunology (78 citations). Tara Gregory has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Jesús G. Berdeja, Steven Trifilio, Scott C. Howard, Ali McBride, David N. Wald, William Tse, Yin Xiong, Adam D. Cohen, Eric Ostertag and Devon J. Shedlock. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of Clinical Oncology, British Journal of Haematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.